{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T08:54:21Z","timestamp":1655369661760},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/mjt.0b013e318032587d","type":"journal-article","created":{"date-parts":[[2009,1,13]],"date-time":"2009-01-13T08:13:54Z","timestamp":1231834434000},"page":"24-34","source":"Crossref","is-referenced-by-count":3,"title":["Atherothrombosis and the Management of the Vulnerable Vascular Patient"],"prefix":"10.1097","volume":"16","author":[{"given":"Rohit","family":"Arora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fasi","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"Suppl 1","key":"R1-7-20210202","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1331\/154434504322904569","article-title":"Atherothrombosis: epidemiology, pathophysiology, and prevention.","volume":"44","author":"Munger","year":"2004","journal-title":"J Am Pharm Assoc"},{"key":"R2-7-20210202","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1161\/CIRCULATIONAHA.105.537878","article-title":"Pathophysiology of coronary artery disease.","volume":"111","author":"Libby","year":"2005","journal-title":"Circulation"},{"key":"R3-7-20210202","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2005.03.075","article-title":"Atherothrombosis and high-risk plaque: part II: approaches by noninvasive computed tomographic\/magnetic resonance imaging.","volume":"46","author":"Fuster","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl B","key":"R4-7-20210202","first-page":"3B","article-title":"Diffuse coronary disease and atherothrombosis: a rationale for long-term therapy to prevent recurrent ischemic events.","volume":"15","author":"Bhatt","year":"2003","journal-title":"J Invasive Cardiol"},{"key":"R5-7-20210202","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM200009283431303","article-title":"Multiple complex coronary plaques in patients with acute myocardial infarction.","volume":"343","author":"Goldstein","year":"2000","journal-title":"N Engl J Med"},{"key":"R6-7-20210202","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0021-9150(02)00129-6","article-title":"C-reactive protein and multiple complex coronary artery plaques in patients with primary unstable angina.","volume":"164","author":"Zairis","year":"2002","journal-title":"Atherosclerosis"},{"key":"R7-7-20210202","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/01.CIR.0000025609.13806.31","article-title":"Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study.","volume":"106","author":"Rioufol","year":"2002","journal-title":"Circulation"},{"key":"R8-7-20210202","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0735-1097(01)01135-4","article-title":"Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study.","volume":"37","author":"Asakura","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R10-7-20210202","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.STR.0000082382.42061.EE","article-title":"Ten-year survival after first-ever stroke in the Perth Community Stroke Study.","volume":"34","author":"Hardie","year":"2003","journal-title":"Stroke"},{"key":"R11-7-20210202","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.ehj.2004.08.009","article-title":"Mortality following non-ST elevation acute coronary syndrome: 4 years follow-up of the PRAIS UK Registry (Prospective Registry of Acute Ischaemic Syndromes in the UK).","volume":"25","author":"Taneja","year":"2004","journal-title":"Eur Heart J"},{"issue":"Suppl 4","key":"R12-7-20210202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00019053-200422004-00004","article-title":"The burden of coronary, cerebrovascular and peripheral arterial disease.","volume":"22","author":"Bakhai","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"R14-7-20210202","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA"},{"key":"R17-7-20210202","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00132577-200203000-00004","article-title":"Critical pathway for unstable angina and non-ST elevation myocardial infarction.","volume":"1","author":"Cannon","year":"2002","journal-title":"Critical Pathways in Cardiology"},{"key":"R18-7-20210202","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/01.CIR.0000087481.55887.C9","article-title":"From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II.","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"key":"R19-7-20210202","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1161\/01.CIR.0000012528.89469.8E","article-title":"A new paradigm for plaque stabilization.","volume":"105","author":"Ambrose","year":"2002","journal-title":"Circulation"},{"key":"R20-7-20210202","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1161\/01.CIR.98.18.1860","article-title":"Chang WC, et al; for the GUSTO-IIb Investigators. Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators.","volume":"98","author":"Armstrong","year":"1998","journal-title":"Circulation"},{"key":"R25-7-20210202","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2337\/diacare.26.12.3333","article-title":"Peripheral arterial disease in people with diabetes.","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"R26-7-20210202","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.HYP.0000196686.85286.9c","article-title":"Automated oscillometric determination of the ankle-brachial index provides accuracy necessary for office practice.","volume":"47","author":"Beckman","year":"2006","journal-title":"Hypertension"},{"key":"R27-7-20210202","first-page":"S1","article-title":"Management of peripheral arterial disease (PAD).","volume":"31","author":"Dormandy","year":"2000","journal-title":"J Vasc Surg"},{"key":"R29-7-20210202","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary of the third Report of the National Cholesterol Education Program (NCEP).","volume":"285","year":"2001","journal-title":"JAMA"},{"issue":"Suppl 4","key":"R31-7-20210202","doi-asserted-by":"crossref","first-page":"431S","DOI":"10.1378\/chest.108.4_Supplement.431S","article-title":"Antithrombotic therapy in peripheral arterial occlusive disease.","volume":"108","author":"Clagett","year":"1995","journal-title":"Chest"},{"key":"R32-7-20210202","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0039-6109(16)46683-1","article-title":"Intermittent claudication: the natural history.","volume":"75","author":"McDermott","year":"1995","journal-title":"Surg Clin North Am"},{"key":"R33-7-20210202","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE).","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"R34-7-20210202","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.","volume":"345","year":"2001","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"R41-7-20210202","doi-asserted-by":"crossref","first-page":"483S","DOI":"10.1378\/chest.126.3_suppl.483S","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke.","volume":"126","author":"Albers","year":"2004","journal-title":"Chest"},{"key":"R42-7-20210202","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jstrokecerebrovasdis.2004.05.002","article-title":"Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: a guideline for primary care physicians from the National Stroke Association Work Group on Recurrent Stroke Prevention.","volume":"13","author":"Hanley","year":"2004","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R43-7-20210202","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1197\/aemj.9.11.1146","article-title":"Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative.","volume":"9","author":"Hoekstra","year":"2002","journal-title":"Acad Emerg Med"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00045391-200901000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:39:04Z","timestamp":1618036744000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-200901000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e318032587d","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}